D. Bouros (Alexandroupolis, Greece)
Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis K. Antoniou, G. Soufla, F. Economidou, A. Proklou, R. Lymbouridou, H. Papadaki, N. Siafakas (Heraklion, Greece)
| |
Idiopathic pulmonary fibrosis: asbestos exposure, smoking and lung cancer risk J. Harris, I. Johnston, R. Rudd, P. Cullinan (London, Nottingham, United Kingdom)
| |
Down-regulation of inhibitory of growth family member 4(ING4) in idiopathic pulmonary fibrosis (IPF). Correlation with disease progression A. Tzouvelekis, G. Zacharis, V. Aidinis, V. Harokopos, P. Steiropoulos, I. Sotiriou, M. Froudarakis, S. Anevlavis, R. Tringidou, A. Karameris, D. Bouros (Alexandroupolis, Athens, Greece)
| |
Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis N. Barlo, C. van Moorsel, H. Ruven, P. Zanen, J. van den Bosch, J. Grutters (Nieuwegein, Utrecht, Netherlands)
| |
Prognostic factors of idiopathic pulmonary fibrosis diagnosed by surgical lung biopsy J. Shiihara, T. Ogura, T. Kato, E. Hagiwara, A. Matsushima, T. Baba, T. Shinohara, T. Endo, H. Takahashi, T. Yazawa, T. Takemura (Yokohama, Tokyo, Japan)
| |
Medical research council dyspnea scale: the relationship with cardiopulmonary exercise test and 6-minute distance walking test in idiopathic pulmonary fibrosis E. Manali, P. Lyberopoulos, C. Triantafillidou, L. Kolilekas, C. Sotiropoulou, J. Milic-Emili, C. Roussos, S. Papiris (Athens, Greece; Quebec, Canada)
| |
Azithromycin in a bleomycin mouse model: finding the holy grail for pulmonary fibrosis? W. Wuyts, R. Vos, B. Vanaudenaerde, S. De Vleeschauwer, M. Rinaldi, W. Janssens, M. Demedts, M. Thomeer, E. Verbeken, G. Verleden (Leuven, Belgium)
| |
Bronchoalveolar lavage and peripheral blood NK cells in idiopathic interstitial pneumonias D. Papakosta, K. Manika, G. Kyriazis, E. Gounari, T. Kontakiotis, L. Sichletidis (Exohi Thessaloniki, Greece)
| |
Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) G. Pinis, A. Dyczek, J. Szczeklik, G. Przybylski, J. Chorostowska-Wynimko, A. Rozy, A. Szpechcinski, J. Golinska, P. Kopinski (Krakow, Bydgoszcz, Warszawa, Poland)
| |
Pathophysiology of exercise limitation in subjects with idiopathic pulmonary fibrosis A. Boutou, N. Havouzis, C. Nakou, I. Trigonis, G. Pitsiou, S. Tryfon, T. Kontakiotis, D. Papakosta, P. Argyropoulou, I. Stanopoulos (Thessaloniki, Greece)
| |
Detection of herpes simplex virus type-1 (HSV-1) in lung tissue and bronchoalveolar lavage fluid (BALF) of patients with fibrotic idiopathic interstitial pneumonias (f-IIPs) I. Lasithiotaki, K. Antoniou, R. Lymbouridou, K. Karagiannis, D. Spandidos, N. Siafakas, G. Sourvinos (Heraklion, Greece)
| |
Phenotypical and molecular characteristics of bone marrow mesenchymal stem cells in rheumatoid lung A. Proklou, K. Antoniou, G. Gvazava, G. Soufla, K. Christina, R. Lymbouridou, K. Karagiannis, I. Lasithiotaki, N. Siafakas (Heraklion, Greece)
| |
Usefulness of skeletal muscle MRI in the diagnosis of polymyositis initially presenting with interstitial lung disease (ILD) M. Saigusa, M. Arita, H. Nakagawa, M. Noyama, T. Ishida (Kurashiki, Japan)
| |
Bronchoalveolar lavage in interstitial lung disease associated with collagen vascular disorders T. M. Alfaro, J. Cemlyn Jones, S. Freitas, C. Robalo Cordeiro (Coimbra, Portugal)
| |
Toll-like receptor 4 is overexpressed in bronchoalveolar lavage fluid of patients with fibrotic idiopathic interstitial pneumonias (F-IIPs): preliminary results K. Karagiannis, K. Antoniou, G. Margaritopoulos, A. Proklou, I. Lasithiotaki, R. Lymbouridou, H. Koutala, D. Moraitaki, N. Siafakas (Heraklion, Greece)
| |
Differential expression of let-7d in different types of idiopathic fibrotic lung disease A. Tzouvelekis, K. Pandit, G. Zacharis, A. Karameris, P. Steiropoulos, M. Froudarakis, N. Kaminski, D. Bouros (Alexandroupolis, Athens, Greece; Pittsburgh, United States Of America)
| |
Sftpc mutations are a common cause of adult familial idiopathic interstitial pneumonia C. H. M. van Moorsel, M. F. M. van Oosterhout, H. H. T. Ruven, J. M. M. van den Bosch, J. C. Grutters (Nieuwegein, Netherlands)
| |
Comparison of brain natriuretic peptide to n-terminal pro brain natriuretic peptide in idiopathic interstitial pneumonia T. Corte, S. Wort, M. Gatzoulis, P. Macdonald, A. Wells (London, United Kingdom; Sydney, Australia)
| |
Clinicoradiological features of chronic fibrosing interstitial pneumonia with smoking history A. Kaga, F. Sakai, Y. Usui, K. Kobayashi, M. Nagata, K. Hagiwara, M. Kanazawa (Saiatama, Saitama, Japan)
| |